This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
17
Check minimum number of events None
17
Include endpoints None
17
Remove individuals based on genotype QC
15
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Disorders of fatty-acid metabolism based on the number of shared cases.
Broader endpoints:
- Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Factors influencing health status and contact with health services
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 15 | 10 | 5 |
Unadjusted prevalence (%) | 0.00 | 0.00 | 0.00 |
Mean age at first event (years) | 37.04 | 36.80 | 37.51 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: E4_FATTYACID – Disorders of fatty-acid metabolism
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Disorders of fatty-acid metabolism
↥Endpoint not on priority list, no data to show.